Page last updated: 2024-08-24

triazoles and Cronobacter Infections

triazoles has been researched along with Cronobacter Infections in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Aboklaish, AF; Brem, J; Jackson, DE; Langley, GW; Schofield, CJ; Tselepis, L; Tyrrell, JM; Walsh, TR; Widlake, E1
Kirby, JE; Zulauf, KE1
Kim, KH; Park, KW; Yim, CB1

Other Studies

3 other study(ies) available for triazoles and Cronobacter Infections

ArticleYear
In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae.
    International journal of antimicrobial agents, 2020, Volume: 56, Issue:1

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Cefepime; Drug Combinations; Enterobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Tazobactam; Triazoles

2020
Discovery of small-molecule inhibitors of multidrug-resistance plasmid maintenance using a high-throughput screening approach.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 11-24, Volume: 117, Issue:47

    Topics: Amines; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Benzimidazoles; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; DNA Replication; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli; High-Throughput Screening Assays; Meropenem; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Plasmids; Quinazolines; Repressor Proteins; Triazoles

2020
Comparative activities of novel beta-lactamase inhibitors, 6-exomethylene penamsulfones (CH1240, CH2140) in experimental mouse infection model.
    Archives of pharmacal research, 1998, Volume: 21, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Citrobacter; Clavulanic Acid; Enterobacteriaceae Infections; Enzyme Inhibitors; Escherichia coli Infections; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Penicillanic Acid; Pseudomonas Infections; Sulbactam; Triazoles

1998